Dr. Ryan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4150 Clement St # 111-R
San Francisco, CA 94121Phone+1 415-750-2105Fax+1 415-750-6920
Education & Training
- University of California (San Francisco)Fellowship, Gastroenterology, 1988 - 1991
- University of California (San Francisco)Residency, Internal Medicine, 1984 - 1986
- Perelman School of Medicine at the University of PennsylvaniaClass of 1984
Certifications & Licensure
- CA State Medical License 1986 - 2026
- CT State Medical License 1984 - 2019
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 7 citationsAssociation of the patterns of use of medications with mortality of COVID-19 infection: a hospital-based observational study.Arthur W Wallace, Piera M Cirillo, James C Ryan, Nickilou Y Krigbaum, Anusha Badathala
BMJ Open. 2021-12-31 - Novel Method for Reduction of Distal Radius Fractures.Steven Mennona, Daniel Mascarenhas, Anna Green, Todd Alter, James C. Ryan
Journal of Orthopaedic Trauma. 2021-08-01 - 2 citationsSurgical Site Complications in Open Pronation-Abduction Ankle Fracture-Dislocations With Medial Tension Failure Wounds.Case W. Martin, James C. Ryan, Travis S Bullock, John H. Cabot, Ahmed A. Makhani
Journal of Orthopaedic Trauma. 2021-03-22
Press Mentions
- Harvard, Other Top Colleges Are Ditching Required Admission Tests over COVID-19June 16th, 2020
- Why UVA Joined Scores of Other Colleges in Asking Students to Stay off CampusMarch 11th, 2020
Grant Support
- Mechanisms Of Effective Innate Immunity In HCV TreatmentNational Institute Of Allergy And Infectious Diseases2010–2011
- HCV Resolution Correlates With Patterned KIR Expressions On Lymphocytes.National Institute Of Allergy And Infectious Diseases2010–2011
- Control Of Allogenic NK Cell Lysis By Lectin ReceptorsNational Institute Of Allergy And Infectious Diseases1999–2003
- Molecular Activation Of NK Cells Through NKR-P1National Cancer Institute1993–1997
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: